Keyphrases
Confidence Interval
100%
Insulin Resistance
100%
Insulin Sensitizers
100%
Beta-blockers
100%
Differential Effects
100%
Gemini
100%
Carvedilol
100%
Thiazolidinediones
85%
Metformin
71%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
57%
Metoprolol
57%
Hemoglobin A1c (HbA1c)
42%
Treatment Difference
28%
Beneficial Effects
14%
Patients with Diabetes
14%
Metformin Use
14%
Concomitant Use
14%
Patients with Hypertension
14%
Treatment Interaction
14%
Nursing and Health Professions
Confidence Interval
100%
Insulin Resistance
100%
Insulin Sensitizing Agent
100%
Carvedilol
100%
Metformin
85%
Thiazolidinedione
85%
Metoprolol Tartrate
57%
Homeostasis Model Assessment
57%
Hemoglobin A1c
42%
Patient with Diabetes
14%
Patient with Hypertension
14%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
100%
Insulin Sensitizing Agent
100%
Carvedilol
100%
Metformin
85%
Thiazolidinedione
85%
Metoprolol Tartrate
57%
Hemoglobin A1c
42%